4 min read
ASCO 2026: RAS Is No Longer Undruggable
For decades, oncologists and drug developers shared an undeniable truth: KRAS – one of the most commonly mutated genes...
Veristat is excited to join over 700 clinical research professionals from the bay area to discuss strategies for clinical outsourcing and address the clinical operations challenges that arise throughout the clinical development and submission process at the Outsourcing in Clinical Trials West Coast 2017 conference.
The conference will cover many exciting topics including:
Meet up with Veristat while you at OCT West! Don’t forget to stop by our booth #7 to meet with our experts to talk about the challenges you are facing with your clinical trial design, execution and regulatory submissions.
Fill out the form on the right to schedule a specific time to meet with Jessica Young or Kimberly Britt at the conference.
4 min read
Jun 15, 2026 Veristat News
For decades, oncologists and drug developers shared an undeniable truth: KRAS – one of the most commonly mutated genes...
10 min read
Jun 12, 2026 Veristat Blog
This May 2026 regulatory update highlights multiple guidances issued by the FDA across cell and gene therapy, clinical...